References
- Stebbing J, Marvin V, Bower M. The evidence-based treatment of AIDS-related non-Hodgkin’s lymphomas. Cancer Treat Rev 2004;30:24–53.
- Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-associated non-Hodgkin’s lymphoma. Lancet 1991;337:805–9.
- Biggar RJ, Rosenberg PS, Cote T. Kaposi’s sarcoma and non- Hodgkin’s lymphoma following the diagnosis of AIDS. Multistate AIDS/Cancer Match Study Group. Int J Cancer 1996;68:754–7587.
- Mocroft A, Katlama C, Johnson AM, Pradier C, Antunes F, Mulcahy F, et al. AIDS across Europe, 1994–98: the EuroSIDA study. Lancet 2000;356:291–6.
- CASCADE Collaboration. Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol 2002;31:951–398.
- Matthews GV, Bower M, Mandalia S, Powles T, Nelson MR, Gazzard BG. Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood 2000;96:2730–4.
- Bhaskaran K, Brettle R, Porter K, et al. Systemic non- Hodgkin’s lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors. AIDS 2004; 18:673–81.
- Hausermann P, Khanna N, Buess M, et al. Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation. Dermatology 2004;208: 287–90.
- Cohen Y, Amir G, Schibi G, Amariglio N, Pollack A. Rapidly progressive diffuse large B-cell lymphoma with initial clinical presentation mimicking seronegative Wegener’s granulomatosis. Eur J Haematol 2004;73:134–8.